Analyst Price Targets — MYO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 10, 2026 1:13 pm | Craig Knickerbocker | Craig-Hallum | $1.10 | $0.68 | StreetInsider | Myomo Inc. (MYO) PT Lowered to $1.10 at Craig-Hallum: "remains a show me story" |
| June 23, 2025 1:35 pm | — | Craig-Hallum | $8.00 | $2.27 | TheFly | Myomo price target lowered to $8 from $10 at Craig-Hallum |
| March 11, 2025 12:57 pm | — | Craig-Hallum | $11.00 | $5.87 | TheFly | Myomo price target raised to $11 from $9 at Craig-Hallum |
| July 31, 2024 7:01 am | Chase Knickerbocker | Craig-Hallum | $7.00 | $4.44 | TheFly | Myomo initiated with a Buy at Craig-Hallum |
| July 10, 2024 3:33 pm | Scott Henry | Industrial Alliance Securities | $5.75 | $4.97 | TheFly | Myomo price target raised to $5.75 from $5.25 at Alliance Global Partners |
| May 20, 2024 8:41 am | Ben Haynor | Lake Street | $3.50 | $1.82 | TheFly | Myomo initiated with a Buy at Lake Street |
Latest News for MYO
Myomo, Inc. (MYO) Q4 2025 Earnings Call Transcript
Myomo, Inc. (MYO) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.01 per share a year ago.
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025. “We delivered 2025 revenue at the midpoint of our updated guidance range with record…
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include the…
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026. Management will hold a conference call…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MYO.
U.S. House Trading
No House trades found for MYO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.